PD184352(CI-1040)

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	3-5days	$100.00	Visible after login	- +
10 mg	3-5days	$160.00	Visible after login	- +
25 mg	3-5days	$290.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

5 mg

3-5days

$100.00

Visible after login

- +

10 mg

3-5days

$160.00

Visible after login

- +

25 mg

3-5days

$290.00

Visible after login

- +

Product Overview

Product Name	PD184352(CI-1040)
CAS	212631-79-3
Formula	C17H14ClF2 IN2O2
MW	478.66
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

PD184352 (PD-184352; CI-1040), an analog of benzhydroxamate, is an orally bioactive, specific, allosteric/non-ATP competitive MEK1/2 inhibitor with potential anticancer activity. In cell-based assays, it inhibits MEK1/2 with IC50 values of 17 nM and exhibits a 100-fold preference for MEK1/2 over MEK5. In mouse xenograft models, it exhibits strong in vitro anti-proliferative activity and significant in vivo antitumor efficacy.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

Bedaquiline (TMC207; R207910)

843663-66-1 98+%

CL2505

trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]-cyclohexaneacetic acid

1109276-89-2 98+%

PD184352(CI-1040)

Chemical safety data sheet(MSDS)